Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine plus psychological treatment for cannabis use disorder
IRCT20161026030510N5Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in cannabis use disorder (CUD), sponsored by Iran University of Medical Sciences. Started Feb 2023; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on IRCT20161026030510N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161026030510N5.